Efficacy and Safety of Oral Azelaprag Plus Once Weekly Tirzepatide Compared with Tirzepatide Alone in Participants with Obesity Aged 55 Years and Over
Trial details
- Registry ID
- NCT06515418
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as BGE-105
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Efficacy and Safety of Oral Azelaprag Plus Once Weekly Tirzepatide Compared with Tirzepatide Alone in Participants with Obesity Aged 55 Years and OverNCT06515418 | BIOA | Phase 2 | Terminated | 2025-02-06Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |